1 |
100 mg elx/50 mg tez/75 mg iva fixed dose combination |
- |
- |
- |
- |
299 1件: 299 💬 |
2 |
50 mg elx/25 mg tez/37.5 mg iva fixed dose combination |
- |
- |
- |
- |
299 1件: 299 💬 |
3 |
A fixed-dose combination of 95 mg clarithromycin, 45 mg rifabutin, and 10 mg clofazimine |
Clarithromycin |
3件: D00276 D00276, D00278 D00278, D00424 D00424 💬 |
- |
- |
096 1件: 96 💬 |
4 |
Calcium and vitamin d combination |
Calcium |
- |
- |
- |
013 1件: 13 💬 |
5 |
Combination |
- |
- |
- |
- |
046 1件: 46 💬 |
6 |
Combination antiviral therapy |
- |
- |
- |
- |
093 1件: 93 💬 |
7 |
Combination fish oil and borage seed oil |
Fish oil |
- |
- |
- |
046 1件: 46 💬 |
8 |
Combination injection of epo and g-csf |
Filgrastim |
1件: D03235 D03235 💬 |
CSF3R 1件: CSF3R 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
006 1件: 6 💬 |
9 |
Combination of a single dose anti-cd20 antibody and bortezomib |
Bortezomib |
1件: D03150 D03150 💬 |
PSMB5 1件: PSMB5 💬 |
Alzheimer disease 8件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia |
061 1件: 61 💬 |
10 |
Combination of fish oil and colesevelam |
Colesevelam |
2件: D03582 D03582, D07743 D07743 💬 |
- |
- |
260 1件: 260 💬 |
11 |
Combination of minocycline and mtx or mtx alone |
Minocycline |
2件: D00850 D00850, D05045 D05045 💬 |
- |
- |
046 1件: 46 💬 |
12 |
Combination of protein a immunoadsorption, rituximab, dexamethasone plus azathioprine |
Azathioprine |
12件: D00238 D00238, D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592, D02994 D02994, D03033 D03033 💬 |
MS4A1 2件: MS4A1, NR3C1 💬 |
Hematopoietic cell lineage 2件: Hematopoietic cell lineage, Neuroactive ligand-receptor interaction |
035 1件: 35 💬 |
13 |
Combination of thrombopoietin mimetic and cyclosporin a |
Cyclosporine |
1件: D00184 D00184 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
060 1件: 60 💬 |
14 |
Combination oral budesonide and rectal hydrocortisone |
Budesonide |
2件: D00088 D00088, D00246 D00246 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
097 1件: 97 💬 |
15 |
Combination product (natpara) and drug or supplements [disease and drug registry] |
- |
- |
- |
- |
235 1件: 235 💬 |
16 |
Combination product: device: axially oscillating sphere dry powder inhaler (aos dpi) |
- |
- |
- |
- |
086 1件: 86 💬 |
17 |
Combination product: active treatment with dual therapy |
- |
- |
- |
- |
002 1件: 2 💬 |
18 |
Combination product: beclomethasone dipropionate in addition to mc-evoo |
Beclomethasone dipropionate |
2件: D00689 D00689, D07495 D07495 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
097 1件: 97 💬 |
19 |
Combination product: beclomethasone dipropionate in addition to refined oil |
Beclomethasone dipropionate |
2件: D00689 D00689, D07495 D07495 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
097 1件: 97 💬 |
20 |
Combination product: belimumab |
Belimumab |
1件: D03068 D03068 💬 |
TNFSF13B 1件: TNFSF13B 💬 |
Cytokine-cytokine receptor interaction 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
049 1件: 49 💬 |
21 |
Combination product: goldic serum |
- |
- |
- |
- |
070 1件: 70 💬 |
22 |
Combination product: hyperbaric oxygen therapy- |
Oxygen |
1件: D00003 D00003 💬 |
- |
- |
226 1件: 226 💬 |
23 |
Combination product: implantable system for remodulin (treprostinil) |
Treprostinil |
1件: D06213 D06213 💬 |
PTGIR 1件: PTGIR 💬 |
Neuroactive ligand-receptor interaction 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 1件: 86 💬 |
24 |
Combination product: l-dopa 140 mg |
Levodopa |
1件: D00059 D00059 💬 |
DRD1 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 1件: 6 💬 |
25 |
Combination product: l-dopa 35 mg |
Levodopa |
1件: D00059 D00059 💬 |
DRD1 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 1件: 6 💬 |
26 |
Combination product: l-dopa 70mg |
Levodopa |
1件: D00059 D00059 💬 |
DRD1 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 1件: 6 💬 |
27 |
Combination product: l-dopa 70mg/carbidopa 7mg |
Carbidopa |
2件: D00059 D00059, D00558 D00558 💬 |
DDC 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 1件: 6 💬 |
28 |
Combination product: mavrilimumab |
Mavrilimumab |
1件: D09930 D09930 💬 |
CSF2RA 1件: CSF2RA 💬 |
Cytokine-cytokine receptor interaction 4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer |
041 1件: 41 💬 |
29 |
Combination product: methotrexate |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 1件: 46 💬 |
30 |
Combination product: nd0612 solution for sc infusion |
- |
- |
- |
- |
006 1件: 6 💬 |
31 |
Combination product: ofatumumab with ai |
Ofatumumab |
1件: D09314 D09314 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
013 1件: 13 💬 |
32 |
Combination product: ofatumumab with prf |
Ofatumumab |
1件: D09314 D09314 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
013 1件: 13 💬 |
33 |
Combination product: prp combined magnovision |
- |
- |
- |
- |
090 1件: 90 💬 |
34 |
Combination product: transcon pth |
- |
- |
- |
- |
235 1件: 235 💬 |
35 |
Combination product: treprostinil via implanted pump |
Treprostinil |
1件: D06213 D06213 💬 |
PTGIR 1件: PTGIR 💬 |
Neuroactive ligand-receptor interaction 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 1件: 86 💬 |
36 |
Combination product: twice daily 90 mg hydrocortisone acetate suppository administered with sephure applicator |
Acetate |
2件: D00088 D00088, D00165 D00165 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
097 1件: 97 💬 |
37 |
Combination steroid |
- |
- |
- |
- |
046 1件: 46 💬 |
38 |
Combination therapy with vigabatrin and prednisolone |
Prednisolone |
9件: D00472 D00472, D00535 D00535, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
ABAT 2件: ABAT, NR3C1 💬 |
Alanine, aspartate and glutamate metabolism 8件: Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Metabolic pathways, Neuroactive ligand-receptor interaction, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism |
145 1件: 145 💬 |
39 |
Continuation of current haart (boosted protease inhibitor [pi] combination + 2 nrtis) |
- |
- |
- |
- |
265 1件: 265 💬 |
40 |
Conventional dmard combination |
- |
- |
- |
- |
046 1件: 46 💬 |
41 |
Cytotoxic combination |
- |
- |
- |
- |
056 1件: 56 💬 |
42 |
Device: abatacept combination product (acp) |
Abatacept |
1件: D03203 D03203 💬 |
CD80 2件: CD80, CD86 💬 |
Allograft rejection 12件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis |
046 1件: 46 💬 |
43 |
Eflornithine plus nifurtimox combination therapy |
Eflornithine |
2件: D00833 D00833, D07883 D07883 💬 |
ODC1 1件: ODC1 💬 |
Arginine and proline metabolism 3件: Arginine and proline metabolism, Glutathione metabolism, Metabolic pathways |
065 1件: 65 💬 |
44 |
Ezetimibe+simvastatin drug combination |
Ezetimibe |
2件: D00434 D00434, D01966 D01966 💬 |
HMGCR 2件: HMGCR, NPC1L1 💬 |
AMPK signaling pathway 5件: AMPK signaling pathway, Bile secretion, Fat digestion and absorption, Metabolic pathways, Terpenoid backbone biosynthesis |
049 1件: 49 💬 |
45 |
Fixed dose combination ciprofloxacin/celecoxib |
Celecoxib |
3件: D00186 D00186, D00567 D00567, D02216 D02216 💬 |
PTGS2 1件: PTGS2 💬 |
Alzheimer disease 22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
002 1件: 2 💬 |
46 |
Infliximab and azathioprine combination at week 0 |
Azathioprine |
3件: D00238 D00238, D02598 D02598, D03033 D03033 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 1件: 96 💬 |
47 |
Infliximab and azathioprine combination at week 14 |
Azathioprine |
3件: D00238 D00238, D02598 D02598, D03033 D03033 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 1件: 96 💬 |
48 |
Lum/iva fixed-dose combination |
- |
- |
- |
- |
299 1件: 299 💬 |
49 |
Lumacaftor plus ivacaftor combination |
Ivacaftor |
2件: D09916 D09916, D10134 D10134 💬 |
CFTR 1件: CFTR 💬 |
ABC transporters 8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway |
299 1件: 299 💬 |
50 |
Lumacaftor, ivacaftor drug combination |
Ivacaftor |
2件: D09916 D09916, D10134 D10134 💬 |
CFTR 1件: CFTR 💬 |
ABC transporters 8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway |
299 1件: 299 💬 |
51 |
Nebulized combination ipratropium bromide with salbutamol |
Ipratropium |
2件: D02147 D02147, D02212 D02212 💬 |
ADRB2 6件: ADRB2, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 |
Adrenergic signaling in cardiomyocytes 17件: Adrenergic signaling in cardiomyocytes, Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, cAMP signaling pathway, cGMP-PKG signaling pathway |
086 1件: 86 💬 |
52 |
Nifurtimox-eflronithine combination treatment (nect) |
Nifurtimox |
1件: D00833 D00833 💬 |
- |
- |
065 1件: 65 💬 |
53 |
Nutraceutical combination |
- |
- |
- |
- |
096 1件: 96 💬 |
54 |
Other: ibuprofen and isosorbide dinitrate combination |
Ibuprofen |
6件: D00126 D00126, D00347 D00347, D00516 D00516, D01122 D01122, D04490 D04490, D06606 D06606 💬 |
PTGS1 2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
113 1件: 113 💬 |
55 |
Other: iv steroids combination alone |
- |
- |
- |
- |
041 1件: 41 💬 |
56 |
Part 2, jm-010 combination group a |
- |
- |
- |
- |
006 1件: 6 💬 |
57 |
Part 2, jm-010 combination group b |
- |
- |
- |
- |
006 1件: 6 💬 |
58 |
Ph-combination therapy |
- |
- |
- |
- |
086 2件: 86, 88 💬 |
59 |
Piperacillin-tazobactam combination product |
Piperacillin |
4件: D00466 D00466, D00660 D00660, D02251 D02251, D08380 D08380 💬 |
- |
- |
299 1件: 299 💬 |
60 |
Rapamycin-calcitriol combination |
Calcitriol |
2件: D00129 D00129, D00753 D00753 💬 |
MTOR 2件: MTOR, VDR 💬 |
AMPK signaling pathway 54件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Mineral absorption, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Tuberculosis, Type II diabetes mellitus, mTOR signaling pathway |
158 1件: 158 💬 |
61 |
Rhtpo in combination with rituximab |
Recombinant Human Thrombopoietin |
1件: D02994 D02994 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
063 1件: 63 💬 |
62 |
Tadalafil and ambrisentan upfront combination therapy |
Ambrisentan |
2件: D02008 D02008, D07077 D07077 💬 |
EDNRA 2件: EDNRA, PDE5A 💬 |
Calcium signaling pathway 9件: Calcium signaling pathway, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
051 2件: 51, 86 💬 |
63 |
Tocilizumab and iv steroids combination |
Tocilizumab |
1件: D02596 D02596 💬 |
IL6R 1件: IL6R 💬 |
Coronavirus disease - COVID-19 12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
041 1件: 41 💬 |
64 |
Triple combination therapy |
- |
- |
- |
- |
299 1件: 299 💬 |
65 |
Ursodeoxycholic acid combination of immunosuppressive agents |
Ursodeoxycholic acid |
1件: D00734 D00734 💬 |
NR1H4 1件: NR1H4 💬 |
Bile secretion 1件: Bile secretion |
093 2件: 93, 95 💬 |
66 |
Von willebrand factor and coagulation factor viii in combination |
Beroctocog alfa |
- |
- |
- |
288 1件: 288 💬 |
67 |
Vx-661 plus ivacaftor combination |
Ivacaftor |
1件: D09916 D09916 💬 |
CFTR 1件: CFTR 💬 |
ABC transporters 8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway |
299 1件: 299 💬 |